Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness | Haematologica
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the Europ
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
![Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/97b7828a-d445-4dbe-a400-ff41c1daeb01/ggn210037-fig-0001-m.jpg)
Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsiv
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
![PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model](https://i1.rgstatic.net/publication/309957914_Hemolytic_anemia_repressed_hepcidin_level_without_hepatocyte_iron_overload_Lesson_from_Gunther_disease_model/links/5e1ee05692851c3cbe657577/largepreview.png)
PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
![PDF) Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan | Mohammed Naja - Academia.edu PDF) Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan | Mohammed Naja - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/51232148/mini_magick20190126-6719-lv2afz.png?1548494384)